Published in Vopr Onkol on January 01, 1991
The role of breast self-examination in early breast cancer detection (results of the 5-years USSR/WHO randomized study in Leningrad). Eur J Epidemiol (1992) 1.55
Hypothalamic mechanisms of ageing and of specific age pathology--II. on the sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in adaptive homestasis. Exp Gerontol (1979) 1.39
Breast self-examination for the early detection of breast cancer: a USSR/WHO controlled trial in Leningrad. Bull World Health Organ (1987) 1.29
[Interim results of a prospective randomized study of self-examination for early detection of breast cancer (Russia/St.Petersburg/WHO)]. Vopr Onkol (1999) 1.21
[Results of a prospective randomized investigation [Russia (St.Petersburg)/WHO] to evaluate the significance of self-examination for the early detection of breast cancer]. Vopr Onkol (2003) 1.18
Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer. J Cancer Res Clin Oncol (2004) 1.08
Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer. Ann Oncol (1994) 1.03
Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer. J Cancer Res Clin Oncol (2003) 0.94
Clinical trials on adjuvant chemotherapy for breast cancer. Cancer (1986) 0.92
[Absolute diet therapy and antibiotic tolerance in bronchial asthma patients]. Ter Arkh (1996) 0.91
[Preliminary results of the Russia (St.Petersburg)/WHO program for the evaluation of the effectiveness of breast self-examination]. Vopr Onkol (1996) 0.89
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer. Ann Oncol (2014) 0.89
Tissue transglutaminase expression in breast carcinomas. J Exp Clin Cancer Res (2001) 0.85
Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances. Oncology (1982) 0.84
Mammary tumors in HER-2/NEU mice are characterized by low content of estrogen receptors-alpha and absence of progesterone receptors. Bull Exp Biol Med (2003) 0.84
Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume. Int J Androl (2002) 0.83
[The influence of partial androgen deficiency of aging men (PADAM) on the impulse regime of incretion of several hormones and mitotic activity]. Tsitologiia (2006) 0.82
[Excretion of cyclic adenosine monophosphate in breast and lung cancer]. Vopr Onkol (1976) 0.82
[Some aspects of the regeneration process carried out by means of pluripotent stem cells]. Tsitologiia (2008) 0.81
Aromatase in breast cancer tissue--localization and relationship with reproductive status of patients. J Cancer Res Clin Oncol (1996) 0.81
[Changes in the expression of receptors of steroid hormones in the development of partial androgen deficiency of aging men (PADAM)]. Tsitologiia (2005) 0.80
Hereditary breast-ovarian cancer syndrome in Russia. Acta Naturae (2010) 0.80
Comparative study of blood insulin levels in breast and endometrial cancer patients. Neoplasma (1997) 0.79
Endocrine-metabolic criteria for distinguishing two pathogenetic types of breast cancer. Neoplasma (1977) 0.78
[Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes]. Vestn Ross Akad Med Nauk (2013) 0.78
Expression of estrogen receptors-alpha and -beta in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy. Bull Exp Biol Med (2004) 0.78
[Comprehensive radiographic diagnosis of breast cancer]. Vopr Onkol (1996) 0.78
[Immunologic reactivity of breast cancer patients]. Vopr Onkol (1978) 0.78
Geographical distribution of breast cancer in the USSR. Int J Cancer (1984) 0.77
[Characteristics of dyslipidemia in cancer patients]. Vopr Onkol (1986) 0.77
Catecholestrogens excretion in smoking and non-smoking postmenopausal women receiving estrogen replacement therapy. J Steroid Biochem Mol Biol (2000) 0.77
[Combined use of 99mTc-MIBI scintigraphy and ultrasonography (US) in the diagnosis of axillary lymphatic metastasis in patients with breast cancer]. Vopr Onkol (2013) 0.77
Hyperinsulinemia as a factor modifying sensitivity of endometrial carcinoma to hormonal influences. Eur J Gynaecol Oncol (1993) 0.76
Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects. Exp Oncol (2006) 0.76
Hormone-metabolic status in moderately smoking breast cancer patients. Acta Oncol (1997) 0.76
Induction of the estrogen effect-switching phenomenon by ethanol and its correction. Neurosci Behav Physiol (2002) 0.76
[Aromatase gene expression and its modifying factors in breast tumor tissue]. Vopr Onkol (1999) 0.76
[The role of breast cancer stem cells in metastasis]. Vopr Onkol (2015) 0.76
[Immunogenic potential of glanders and melioidosis agents]. Vestn Ross Akad Med Nauk (1997) 0.76
Estrogen content and DNA unwinding in tumor and normal endometrial tissue of aging endometrial cancer patients. Mutat Res (1996) 0.75
Professor Vladimir Dilman. Int J Obes Relat Metab Disord (1995) 0.75
[A decrease in body weight, cholesterol and blood sugar under the influence of phenformin (phenylbiguanide) in patients with cancer and atherosclerosis]. Vopr Onkol (1972) 0.75
[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin]. Vopr Onkol (1975) 0.75
[Progenotoxic shift in mammary adipose tissue (adipogenotoxicosis): association with clinical and biological characteristics of breast cancer]. Vopr Onkol (2008) 0.75
Study of tobacco smoke influence on content of estrogens and DNA flow cytometry data in uterine tissue of rats of different age. Horm Metab Res (1999) 0.75
[Effect of progestin therapy on the level of cytoplasmic receptors in patients with cancer of the corpus uteri]. Vopr Onkol (1989) 0.75
[Decrease of testosterone level in blood of breast cancer patients of reproductive age after neoadjuvant chemotherapy]. Vopr Onkol (2012) 0.75
[Catechol estrogen excretion in women receiving estrogen replacement therapy]. Biull Eksp Biol Med (1999) 0.75
Dependence of clinical course in breast cancer on tumour pathology. Radiobiol Radiother (Berl) (1974) 0.75
[The clinical significance of tumor contour in cancer of the breast]. Vopr Onkol (1969) 0.75
[Protocol of the 500th jubilee meeting of the Society of Oncologists, devoted to the theme of "Hormone-dependent tumors -- pathogenesis and therapy," May 12, 2014]. Vopr Onkol (2014) 0.75
[Steroid hormone excretion and some metabolic indices in children with breast hyperplasia]. Vopr Onkol (1973) 0.75
Criteria of endometrial carcinoma sensitivity to hormone therapy: pathogenetic type of the disease and the tumor reaction to tamoxifen. Eur J Gynaecol Oncol (1993) 0.75
[Search for drugs which decrease the hypothalamic threshold of homeostatic inhibition. I. Results of studies of the product Agr-307. (1st conclusions)]. Agressologie (1971) 0.75
Influence of tobacco smoke on DNA unwinding and uterotrophic effect of estrogens in rats. Cancer Lett (1998) 0.75
[A study of the effect of tobacco smoke on the uterotropic effects of estrogens]. Biull Eksp Biol Med (1997) 0.75
[State of immunological reactivity in breast cancer patients receiving prednisolone treatment]. Vopr Onkol (1979) 0.75
Modification of uterotropic effect of estrogens by whole-body gamma-irradiation. Bull Exp Biol Med (2001) 0.75
[Hormonal status and the clinical course of ovarian cancer]. Akush Ginekol (Mosk) (1978) 0.75
[Effects of tamoxifen and oxyprogesterone caproate on steroid hormone receptors in tumors and indicators of reproductive homeostasis in patients with cancer of the uterine body]. Akush Ginekol (Mosk) (1988) 0.75
[Detection of substances lowering the hypothalamic threshold of homeostatic inhibition. III. Study of Agr 1240]. Agressologie (1977) 0.75
Study of the role of steroid receptors in human breast cancer. Neoplasma (1985) 0.75
[Breast cancer in children]. Vopr Onkol (1975) 0.75
[Relation of urinary excretion of cholesterol in cancer patients to certain hormonal-metabolic parameters and the effect of drugs on this relation]. Vopr Med Khim (1979) 0.75
[Immunohistochemical study of the proliferation of breast cancer cells based on the expression of proliferating cell nuclear antigen (PCNA)]. Vopr Onkol (1998) 0.75
[Family diabetes and its consequences in cancer patients]. Vopr Onkol (2013) 0.75
[Molecular biological and biochemical features of breast cancer]. Vestn Ross Akad Med Nauk (1998) 0.75
[Postoperative hormone therapy of breast cancer (analysis of overall survival)]. Vopr Onkol (1996) 0.75
[Rare localizations of breast cancer metastasis]. Khirurgiia (Mosk) (1972) 0.75
[Effect of tamoxifen on the content of cytoplasmic steroid hormone receptors of the tumor in patients with cancer of the corpus uteri]. Vopr Onkol (1989) 0.75
[The effect of tobacco smoke on the uterotropic and genotoxic effects of estrogens in the rat uterus]. Ross Fiziol Zh Im I M Sechenova (1997) 0.75
[Prospects for sanatorium-health resort treatment of oncological patients]. Vopr Onkol (1976) 0.75
[Evaluation of the effect of ovariectomy in patients with stage III breast cancer]. Vestn Khir Im I I Grek (1987) 0.75
[Steroid hormone receptors and survival in breast cancer patients]. Vopr Onkol (1986) 0.75
[The nature of hyperinsulinemia (insulin resistance) in endometrial carcinoma: of plasma levels of insulin and c-peptide]. Vopr Onkol (2000) 0.75
[Evaluation of ovarian status in women who received anti-tumor therapy in childhood and adolescence]. Vopr Onkol (2014) 0.75
[Induction by ethanol of 'phenomenon of switching estrogen effect' and its correction]. Ross Fiziol Zh Im I M Sechenova (2001) 0.75
[Neovir, an interferon inductor, modifies expression of steroid hormone receptors in hormone-dependent tissues and restores sensitivity to tamoxifen in patients with inoperable breast cancer]. Vopr Onkol (1996) 0.75
[Comparative study of the proliferation (by detection of Ki-67 antigen) and activity of nucleolar organizer regions in breast cancer cells]. Vopr Onkol (1998) 0.75
[Parameters of estrogen expression in patients with endometrial tumors as prognostic signs of the effectiveness of neoadjuvant antitumor hormone therapy]. Vopr Onkol (1996) 0.75
[Microviscosity of erythrocyte membranes in breast cancer patients: connection with the receptor phenotype of the tumor]. Vopr Onkol (2014) 0.75
Effect of ethanol on uterotropic action of estrogens. Bull Exp Biol Med (2000) 0.75
[Effect of previous diabetes therapy on tumor receptor phenotype in breast cancer: comparison of metformin and sulphonylurea derivatives]. Vopr Onkol (2010) 0.75
[Endocrine-genotoxic switchings as promoter of main noninfectious diseases]. Vestn Ross Akad Med Nauk (2008) 0.75
[Effect of tobacco smoke on the level of estrogens and DNA in the rat uterus]. Ross Fiziol Zh Im I M Sechenova (1999) 0.75
[Gail coefficient as a risk factor and prognosticator for the course of breast cancer: correlation with hormonal and metabolic parameters and clinical and morphologic features]. Vopr Onkol (2008) 0.75
Effect of oxyprogesterone caproate, tamoxifen and their combination on the level of steroid hormone receptors in the tumor, and some parameters of the reproductive system in patients with endometrial cancer. Clin Exp Obstet Gynecol (1990) 0.75
[Metabolic effect of tobacco smoke and "switching" the estrogen effect: mechanism of increased genotoxicity]. Vestn Ross Akad Med Nauk (2001) 0.75
[Determination of the proliferative activity of breast cancer cells using 5-bromo-2'-deoxyuridine in vivo]. Vopr Onkol (1997) 0.75
[Estrogen-dependence of thyroid carcinoma: testing with estradiol preparations and tamoxifen]. Vopr Onkol (2008) 0.75
[Interrelationship between response to neoadjuvant hormone therapy and hormonal-metabolic status in breast cancer patients]. Vopr Onkol (2001) 0.75